Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2359-2372, Vol. 21, No. 7
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.7.2359-2372.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mitochondrial Translation of Saccharomyces cerevisiae
COX2 mRNA Is Controlled by the Nucleotide Sequence
Specifying the Pre-Cox2p Leader Peptide
Nathalie
Bonnefoy,1
Nada
Bsat,2 and
Thomas D.
Fox2,*
Department of Molecular Biology and Genetics,
Cornell University, Ithaca, New York
14853-2703,2 and Centre de
Génétique Moléculaire, Laboratoire propre du CNRS
associé à l'Université Pierre et Marie Curie,
91198 Gif-sur-Yvette Cedex, France1
Received 8 September 2000/Returned for modification 16 October
2000/Accepted 19 January 2001
 |
ABSTRACT |
The mitochondrial gene encoding yeast cytochrome oxidase subunit II
(Cox2p) specifies a precursor protein with a 15-amino-acid leader
peptide. Deletion of the entire leader peptide coding region is known
to block Cox2p accumulation posttranscriptionally. Here, we examined in
vivo the role of the pre-Cox2p leader peptide and the mRNA sequence
that encodes it in the expression of a mitochondrial reporter gene,
ARG8m, fused to the 91st codon of
COX2. We found within the coding sequence antagonistic
elements that control translation: the positive element includes
sequences in the first 14 codons specifying the leader peptide,
while the negative element appears to be within codons 15 to 91. Partial deletions, point mutations, and local frameshifts within the
leader peptide coding region were placed in both the
cox2::ARG8m reporter and in
COX2 itself. Surprisingly, the mRNA sequence of the
first six codons specifying the leader peptide plays an important
role in positively controlling translation, while the amino acid
sequence of the leader peptide itself is relatively unconstrained. Two
mutations that partially block translation can be suppressed by nearby
sequence substitutions that weaken a predicted stem structure
and by overproduction of either the COX2 mRNA-specific
translational activator Pet111p or the large-subunit mitochondrial
ribosomal protein MrpL36p. We propose that regulatory elements embedded
in the translated COX2 mRNA sequence could play a role,
together with trans-acting factors, in coupling regulated synthesis of nascent pre-Cox2p to its insertion in the mitochondrial inner membrane.
 |
INTRODUCTION |
Mitochondrial genetic systems have
evolved to supply a limited number of subunits of enzymes that carry
out respiration and oxidative phosphorylation in the inner membrane.
These subunits, encoded in mitochondrial DNA (mtDNA), are assembled
with imported products of nuclear genes by mechanisms that are poorly
understood but genetically complex, at least in Saccharomyces
cerevisiae (18, 19, 54). It seems likely that the
expression of mitochondrial and nuclear genes that encode subunits of
energy-transducing enzymes is coordinated with the assembly of those
enzymes, although no clear mechanisms for this have been elucidated.
In this study, we have focused closely on expression of the
mitochondrial gene encoding cytochrome c oxidase subunit II,
Cox2p. Like most, if not all, yeast mitochondrial genes,
COX2 is expressed under the control of a nuclearly encoded
inner-membrane-bound mRNA-specific translational activator protein,
Pet111p (14, 17). Pet111p is tightly associated with the
inner mitochondrial membrane and is present at levels that limit
COX2 expression (17). This translational
activator functionally interacts with the COX2 mRNA 5'
untranslated leader (5'-UTL) and promotes translation by an unknown
mechanism (31, 39) that is conserved in other budding
yeasts (10). Translation of other coding sequences
artificially fused to the COX2 mRNA 5'-UTL is also
activated by Pet111p (6, 17, 32), indicating that open
reading frame sequences do not play a role in this activation step.
Furthermore, its interaction with the COX2 mRNA 5'-UTL
appears to be important for correct localization of Cox2p synthesis
within the organelle (43).
Cox2p is synthesized as a precursor with a 15-amino-acid leader peptide
(41, 46) that is cleaved in the intermembrane space after
translocation of the amino terminal domain of pre-Cox2p through the
membrane (4, 37, 41, 44). Translocation of the
amino-terminal domain is not well understood mechanistically but
depends on the highly conserved inner membrane protein Oxalp (5,
21, 22, 27) and is thought to be cotranslational (14,
40). While the leader peptide causes membrane association of a
soluble passenger protein fused to it, it does not function as a
classical signal sequence since it is incapable of directing translocation of the passenger protein through the inner membrane (21). Nucleic acid sequence comparisons indicate that the
pre-Cox2p leader peptides of various budding yeast species, including
Neurospora crassa, and plants are not highly
conserved (20, 25). Mammalian Cox2p entirely lacks a
leader peptide (3, 50).
We previously began a study of the function of the pre-Cox2p leader
peptide by deleting the codons that specify it from the S. cerevisiae COX2 mitochondrial gene (53). This
deletion dramatically reduced the accumulation of Cox2p and caused a
severe respiratory defect, but did not affect COX2 mRNA
levels. The defect was bypassed by a chimeric gene whose product had
the amino-terminal 251 residues of cytochrome b fused to the
remaining COX2 coding sequence (53). However,
the mechanism by which the deletion prevented COX2
expression was not established: it could have affected translation,
membrane insertion, or both.
Here, we examine in more detail the in vivo function of the pre-Cox2p
leader peptide and the mRNA sequence that encodes it by
site-directed mutation of the mtDNA sequence. We determine the effects
of each mutation on functional expression of COX2, which
demands synthesis and assembly of cytochrome oxidase, and on expression
of a reporter gene, ARG8m (fused to the 91st
codon of the COX2 reading frame), which depends only on
translation of the chimeric mRNA. Surprisingly, we find that in the
context of the COX2 coding sequence, the mRNA sequence encoding the leader peptide plays an important role in controlling translation, while the amino acid sequence of the leader peptide itself is relatively unconstrained. Our analysis suggests the existence
of positive and negative regulatory elements embedded in the translated
mRNA sequence specifying the N-terminal portion of pre-Cox2p, which
could play a role in coupling regulated synthesis of the nascent Cox2p
precursor to its insertion in the inner membrane.
 |
MATERIALS AND METHODS |
Strains, media, and genetic techniques.
All strains used in
this study are listed in Table 1, with
the exception of DFS160p0 (MAT
leu2
arg8
URA3
ura3-52 kar1-1 ade2-101 [rho0]) (6,
49). Strain backgrounds were either D273-10B (ATCC 25627) or
DBY947 (36). NB58 comes from the cytoduction of
cox2-20 mitochondria (53) into the
[rho0] derivative of NB40-3C.
cox2-62 and cox2-60 are deletions of sequences
295 to +363 (11) and
63 to +66 (6)
relative to AUG, respectively. Fermentable complete medium was YPDA or
YPGalA: 1% yeast extract, 2% Bacto-Peptone, 100 mg of adenine/liter,
and either 2% glucose or 2% galactose supplemented with 0.1%
glucose. Nonfermentable medium was YPEG: 1% yeast extract, 2%
bacto-peptone, 100 mg of adenine/liter, 3% ethanol, 3% glycerol.
Minimal medium (0.67% yeast nitrogen base without amino acids) was
supplemented with 2% glucose and specific amino acids, with uracil and
adenine as required. Standard genetic methods were as previously
described (15, 42). Yeast nuclear transformation was
carried out using the one-step transformation method (8)
for both library DNA and the plasmids YEp352 (23), pJM20
(33), pJM57 (31), or pNB107 (see below).
Mutagenesis of the leader peptide coding sequence.
The
COX2 plasmid pNB69 and the
cox2::ARG8m plasmid pNB81, which
also contains a marker fragment of COX3, were generated
previously (6). They contain two unique sites surrounding
the leader peptide coding sequence: PacI at
60 relative to
the first COX2 codon and NsiI at +65. These
sites were used to replace the wild-type PacI-NsiI fragment by mutant versions of the
COX2 leader peptide sequence. Novel mutagenized fragments
were created by a two-step PCR (24) using low-error-rate
DeepVent polymerase (NE Biolabs, Inc.). We first cloned the
cox2-22 PacI-NsiI fragment into the PacI and NsiI sites of both pNB69 (to yield
pNB82) and pNB81 (to yield pNB90). We subsequently used pNB82 and pNB90
as backbones in which to insert the other mutagenized
PacI-NsiI fragments since cox2-22
introduces a unique SnaBI site between the PacI
and NsiI sites (see Fig. 5A), allowing improved cloning
efficiency by digestion of the ligation reaction products with
SnaBI. Alternatively, some novel mutations were generated by
the megaprimer method (45) using Taq polymerase
(Boehringer, Inc.). In this case, the template was pNAB1, which
contained the COX2 gene in pBKSII+ (Stratagene, Inc.) as a
HindIII-BamHI fragment. All final plasmid
constructs were confirmed by DNA sequencing using the primer COX2A,
which was complementary to COX2 positions
254 to
237
relative to AUG.
Mitochondrial transformation and genetic manipulations.
Plasmids carrying modified COX2 sequences were introduced
into the [rho0] mitochondria of strain
DFS160p0 (Table 1) by high-velocity microprojectile
bombardment (7, 56). Mitochondrial synthetic
[rho
] transformants were identified, and
their altered COX2 sequences were inserted into
[rho+] mtDNA by recombination and selection of
haploid cytoductants as previously described (6).
cox2 mutants were generated by crossing synthetic
[rho
] transformants with either
[rho+] cox2-60 (NB97) or
cox2-62 (NB40-3C) strains, and
cox2::ARG8m mutants were
generated by crossing synthetic [rho
]
transformants with a [rho+]
cox2-60::ARG8m strain (NB54) or
by recombination with [rho+] cox2
mutant strains. Haploid cytoductants were isolated unless otherwise
indicated. In several cases, we also constructed the desired
[rho+] strain by directly transforming
[rho+] strains (6, 26) carrying
the cox2-60 deletion (NB66 or NB104). This approach allows a
quicker isolation of desired [rho+] strains,
whose phenotypes were identical to those of corresponding mutants
constructed by the two-step method. All mitochondrial mutations were
verified by DNA sequencing (carried out by the Synthesis and Sequencing
Facility in the Cornell Biotechnology Building) following integration
into [rho+] mtDNA and PCR amplification from
total DNA, as previously described (6).
Selection of suppressors and disruption of MRPL36.
Spontaneous revertants of independent subclones of cox2-22
strain NB64, cox2-27 strain NB140 and cox2-43
strain NB178, were selected on YPEG medium after 1- to 4-week
incubations at 28 or 16°C. Revertant phenotypes were confirmed by
streak purification. The COX2 upstream region of revertant
mtDNA was sequenced as described above. Revertants of
cox2-22 were genetically analyzed by two crosses. First, the
spontaneous revertants were crossed to a nuclearly wild-type
[rho0] strain. Second,
[rho0] derivatives of the revertants were
generated (15) and crossed with cox2-22 strain
NB68. In both cases, the respiratory ability of the diploids was
scored. Taken together, the results distinguish nuclear dominant,
nuclear recessive, and mitochondrially inherited suppressor mutations.
Dosage-dependent nuclear suppressors of
cox2-22 were
isolated by transforming strain NB64 with an
S. cerevisiae
genomic library
in the multicopy plasmid YEp13 (
35).
Roughly 6,000 Leu
+ transformants were scored for growth on
YPEG medium at 28°C.
Eleven such transformants exhibited
cosegregation of Leu
+ and Pet
+ phenotypes after
growth under nonselective conditions. Plasmids
from these transformants
were analyzed by partial sequencing of
the inserts by using a
YEp13-specific primer. Nine overlapping
inserts were from chromosome II
(pNB104-type), and two overlapping
inserts were from chromosome XIII
(pNB105-type). Only the pNB104-type
plasmids which were found to also
suppress
cox2-27 were further
analyzed to identify the
suppressing
gene.
The
MRPL36 gene was isolated by cloning the 1.2-kb
XhoI-
SacI fragment from pNB104/40 into the
SalI and
SacI sites of YEp352
(
23)
to yield pNB107.
MRPL36 was largely deleted by replacing
the
0.65-kb internal
BglII-
KpnI fragment of pNB107
with the
BamHI-
KpnI
URA3-containing
fragment from pNB108 (pNB108 is the 1.56-kb
URA3-containing
NsiI fragment from YEp352 that was blunt ended and cloned in
a
YEp351
SmaI site). The resulting plasmid, called pNB109,
carried
a deletion of the whole
MRPL36 coding sequence but
the first eight
codons. The wild-type strain NB80 was transformed
with the 2.1-kb
gel-purified
PstI-
SacI fragment
of pNB109, and Ura
+ transformants were selected. The
disruption was confirmed by
PCR analysis and at the genetic level by
analysis of the linkage
between the deletion marker
URA3 and
LYS2, a gene tightly linked
to
MRPL36. Strains
carrying
mrpL36
::
URA3 were found to be
[
rho
] or [
rho0] by
crossing to a nuclearly wild-type [
rho0]
strain.
Analysis of cellular RNA and proteins.
Total RNA was
prepared and analyzed as previously described (11) except
that the samples were supplemented with ethidium bromide before loading
10 µg in each lane. The COX2 probe was the 1.6-kb
PacI fragment from pJM2 (32). The
cox2::ARG8m probe was the 1.4-kb
PacI-BamHI fragment from pNB81, which contained part of the COX2 gene (approximately from the start of the
mature mRNA to codon 91) and the whole
ARG8m coding sequence. 15S rRNA was probed with
either the 2-kb BamHI fragment from plasmid pYJL25
(52) provided by O. Groudinsky or
XhoI-linearized plasmid pT82 (47).
Total cellular protein was extracted (
58) from cells grown
in YPGalA medium to a mid-exponential phase. Fifty to 200 µg
of total
protein, as indicated, were separated on 10 to 12% polyacrylamide
gels
and probed with monoclonal anti-Cox2p antibodies (obtained
from
Molecular Probes Inc.; provided by G. Dujardin) diluted to
1/5,000,
CCO6 (
38) (obtained from T. Mason) diluted to 1/50,
or
polyclonal anti-Arg8p antibody (
49) diluted to 1/1,000.
The
monoclonal anti-outer membrane porin antibody from Molecular Probes
was provided by G. Dujardin and was diluted to 1/5,000. Secondary
anti-mouse or anti-rabbit antibodies were detected using the Pierce
Inc. chemiluminescent
substrate.
In vivo pulse labeling with [
35S]methionine in the
presence of cycloheximide was performed as previously described
(
15), with
the following modifications. Cells were grown
initially in liquid
1% yeast extract-2% Bacto Peptone-2% raffinose
and then transferred
to synthetic complete medium lacking Met (0.67%
yeast nitrogen
base, 0.08% CSM-Met [Bio 101, Inc.], 2% raffinose).
Cells were
labeled with 5 µCi of [
35S]methionine (1,175 Ci/mmol; NEN, Inc.) for 10 min and then chased
with unlabeled 2.5 mM
methionine for 10 min before chilling and
freezing. Crude mitochondria
were isolated after the conversion
of cells to spheroplasts as
previously described (
58), except
that disruption was by
vortexing with glass
beads.
 |
RESULTS |
Deletion of pre-Cox2p leader peptide coding sequence dramatically
decreases translation.
We previously made 13- and 14-codon
deletions of mtDNA specifying the pre-Cox2p leader peptide (alleles
cox2-20 and cox2-21, respectively) to generate
genes that would encode a leaderless Cox2p protein similar to that of
animals. We observed that both mutations dramatically decreased Cox2p
accumulation and prevented respiratory growth, without altering the
level of COX2 mRNA (53). This could have
been due to decreased stability of the protein, decreased translation
of the mRNA, or both. To distinguish the effects of the leader
peptide deletions on Cox2p synthesis from those on Cox2p function, we
took advantage of a synthetic mitochondrial reporter gene,
ARG8m, which specifies a soluble enzyme
necessary for arginine biosynthesis in the mitochondrion
(49) by fusing it to the COX2 reading frame (6). This
cox2::ARG8m chimeric gene
comprises the first 91 codons of COX2, fused to codon 2 of ARG8m. When inserted precisely in
place of the native COX2 gene in the mitochondrial genome,
cox2::ARG8m complements the
Arg
growth phenotype of a nuclear arg8
mutation and directs the synthesis of a chimeric fusion protein.
However, since the ARG8m sequence used here
specifies the cleavage site for removal of the matrix targeting signal
of pre-Arg8p, this chimeric Cox2p-Arg8p fusion protein is largely
processed to yield mature Arg8p (6). Thus, translation of
the chimeric cox2::ARG8m mRNA
can be assayed by scoring for Arg+ growth independently of
functional constraints on the structure of Cox2p.
Both of the 13- and 14-codon deletion mutations (
cox2-20
and
cox2-21, respectively) were inserted into this
cox2::
ARG8m reporter gene and
placed into the mitochondrial genome by transformation
and homologous
recombination (see Materials and Methods). Neither
the
cox2-20::
ARG8m nor
cox2-21::
ARG8m construct
complemented a nuclear
arg8 mutation at the level of
growth
or directed synthesis of Cox2p-Arg8p, as measured by pulse
labeling
(Fig.
1; data not shown). Furthermore,
neither accumulated
detectable steady-state levels of reporter protein
(Fig.
2). The
lack of Arg8p synthesis was
not due to an mRNA synthesis or stability
defect, since the
chimeric mRNA steady-state level was similar
in the mutant and
wild-type strains (Fig.
2).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 1.
The cox2-20 mutation prevents expression of
the ARG8m reporter fused to COX2
codon 91. (A) The COX2 leader peptide coding region is
in black, other COX2 codons are in white, and the
COX2 mRNA 5'-UTL is indicated by the thin line.
ARG8m codons are in grey. Triangles,
processing sites of the pre-Cox2p leader peptide (black) and the
pre-Arg8p matrix targeting signal (grey); ×, the mutated pre-Cox2p
cleavage site of the cox2-24 mutants, in which
COX2 codons 15 and 16 were changed from AAT GAT (ND) to
AAG CTT (KT) (creating an HindIII site). Strains were
patched on complete glucose medium, replica plated to nonfermentable
medium (YPEG) and minimal medium lacking arginine ( Arg) or containing
arginine (+Arg), and incubated for 2 days at 28°C. In descending
order, the strains used were DL2, NB80, HMD22 (this strain contains the
only chimeric gene used here entirely lacking COX2
codons), NB43, NB65, NB72, NB58, and NB120 (Table 1). (B)
Mitochondrial translation products were radioactively pulse labeled for
10 min in cells treated with cycloheximide (see Materials and Methods).
Protein aliquots normalized for radioactivity were analyzed by
electrophoresis on sodium dodecyl sulfate-15% polyacrylamide gels and
subsequently by phosphorimaging. The positions of the Cox2p-Arg8p
fusion protein and products of endogenous mitochondrial genes are
indicated. The fusion protein coded by
cox2-24::ARG8m migrated slightly
slower than the cox2::ARG8m
fusion protein on this gel and, more dramatically, on others (not
shown) due to the lack of leader peptide processing, and it appears to
have yielded novel degradation products. Mature Arg8p comigrates with
the upper part of the Cox1p band and is difficult to detect after pulse
labeling. Strains were
cox2::ARG8m (NB43),
cox2-60::ARG8m (NB54; this strain
lacks COX2 nucleotides 63 to +66),
cox2-24::ARG8m (NB72), and
cox2-20::ARG8m (NB120).
|
|

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
Deletion of the leader peptide coding region has no
effect on cox2::ARG8m mRNA
levels but prevents accumulation of reporter protein Arg8p. Northern
blot analysis (top two panels) was carried out on total cellular
RNAs from the indicated strains: COX2 arg8 (NB80),
COX2 ARG8 (DL2),
cox2::ARG8m (NB43),
cox2 (NB40-3C),
cox2-20::ARG8m (NB120), and
cox2-21::ARG8m (NB121) (all
strains, except DL2, contain a nuclear
arg8::hisG mutation). The COX2
mRNA (0.85 kb) and
cox2::ARG8m mRNA (1.7 kb)
were detected simultaneously with the COX2 and
cox2::ARG8m probes (see Materials
and Methods), and 15S rRNA hybridization served as a loading control.
Western blot analysis was carried out with 100 µg of total protein
from the indicated strains (as above) by using anti-Arg8p antibody (see
Materials and Methods). Both the mature Arg8p protein (lower band) and
the unprocessed Cox2p-Arg8p fusion protein (upper band) are indicated.
The middle band corresponds to a cross-reacting protein present in
strains lacking a functional ARG8 gene. For unknown reasons,
the strength of this signal is variable (Fig. 5 and 9).
|
|
It was unlikely that the leader peptide deletion mutants were lacking
the Arg8p reporter protein due to degradation of the
chimeric protein,
since cleavage of the pre-Arg8p matrix targeting
sequence should
release mature, wild-type Arg8p from the fusion
protein, as observed
previously (
6). Furthermore, we experimentally
verified
that a mutation causing instability of Cox2p did not
prevent the
accumulation of Arg8p encoded by a chimeric gene.
A mutation that
altered the pre-Cox2p leader peptide processing
site from ND to KT
(
cox2-24) in an otherwise wild-type
COX2 gene
caused a severe respiratory defect and greatly reduced the level
of
Cox2p (Fig.
1 and
3C). However, when this
mutation was inserted
into the
cox2::
ARG8m reporter gene, the
resulting strain was fully Arg
+, synthesized pulse-labeled
Cox2p-Arg8p (Fig.
1), and contained
a normal steady-state level of the
processed Arg8p reporter protein
(not shown). Thus, the defect in
pre-Cox2p processing destabilized
Cox2p but had no effect on Arg8p
translation, confirming that
our
cox2::
ARG8m reporter system can
discriminate between gene expression defects
caused by Cox2p
instability and those caused by reduced translation.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of mutations within the leader peptide coding
region on expression of COX2 and the
cox2::ARG8m reporter gene. (A)
The sequence of the first 18 codons of the wild-type
COX2 open reading frame and the amino acids they specify are
shown for reference. The arrow indicates the leader peptide cleavage
site. Strains carrying the indicated alleles affecting the
COX2 leader peptide coding region in either COX2
or cox2::ARG8m were patched on
complete glucose medium and replica plated to nonfermentable medium
(YPEG) for alleles in COX2 and to minimal medium lacking
arginine ( Arg) or containing arginine (+Arg) for alleles in
cox2::ARG8m. Incubation was for 2 days at 28°C. Periods indicate deleted residues, and the boxed
"R" in bold indicates a mutation of codon 6 from AGA (R) to CGT
(R). The arrow marks the leader peptide cleavage site. The indicated
alleles of COX2 and
cox2::ARG8m, respectively,
correspond to the following strains: COX2 (NB80 and NB43),
cox2-27 (NB117 and NB127), cox2-23 (NB100 and
NB123), cox2-28 (NB118 and NB128), cox2-35 (NB172
and NB135), cox2-22 (NB64 and NB122), cox2-29
(NB119 and NB129), and cox2-20 (NB58 and NB120). (B)
Northern blot analysis was used to detect the COX2 mRNA
and 15S rRNA in total RNA (see Materials and Methods) prepared from
strains with the following alleles: COX2 (NB80),
cox2 (NB40-3C), cox2-22 (NB64), and
cox2-27 (NB117). (C). Western blot analysis probing with the
anti-Cox2p monoclonal antibody CCO6 (38) was used to
detect Cox2p in 100 µg of total protein (see Materials and Methods)
from strains with the following alleles: cox2-22 (NB64),
cox2-24 (NB65), COX2 (HMD21), cox2
(NB73), and cox2-27 (NB140). A faint band of slightly lower
mobility than the wild type, corresponding to unprocessed pre-Cox2p,
was detected in the cox2-24 lane after overexposure (not
shown).
|
|
Taken together, these findings demonstrate that deletion of the
pre-Cox2p leader peptide coding sequence from
cox2::
ARG8m
(
cox2-20::
ARG8m and
cox2-21::
ARG8m) produces
mRNAs that are poorly if at all translated. This result
is very
surprising since in the complete absence of
COX2 codons
[the
cox2(UTL)::
ARG8m allele of
strain HMD22],
ARG8m is efficiently expressed
from the
COX2 locus (Fig.
1). Thus,
the presence of
COX2 codons 15 to 91 in the chimeric mRNA specified
by the
cox2-20::
ARG8m allele
apparently blocks translation of the downstream
ARG8m sequence. On the other hand, fusion of the
COX2 codons 1 to 16
to a variant of
ARG8m lacking its matrix targeting signal did
not prevent the expression
of the reporter (
21). Taken
together, these results suggest
the existence of an element in the
sequence of codons 15 to 91
that inhibits translation and a
compensating positively acting
element within the first 14 codons
that specify the leader
peptide.
Mutations within the leader peptide coding region that reduce
downstream translation.
To define more precisely the leader
peptide coding sequences necessary for efficient translation of the
COX2 and cox2::ARG8m
mRNAs, we constructed a set of mutants harboring small deletions and/or point mutations. In all cases, the initiation codon and the
codons for residues 15 and 16 surrounding the leader peptide cleavage site (ND) were left unchanged. First, three small deletions spanning the remaining 13 codons were created: deletion of
codons 2 to 6 (residues LDLLR, allele cox2-27), deletion
of codons 7 to 10 (residues LQLT, allele cox2-23), and
deletion of codons 11 to 14 (residues TFIM, allele
cox2-28). None of these deletions had a significant effect
on the steady-state levels of either the COX2 or
cox2::ARG8m mRNAs (Fig. 3B
and data not shown), and neither the codons 7-to-10 nor the
codons 11-to-14 deletions detectably affected either respiratory growth or arginine prototrophy (Fig. 3A). In contrast, the codons 2-to-6 deletion, cox2-27, caused decreased respiratory
growth at 28°C, prevented arginine prototrophy when inserted into the reporter construct (Fig. 3A), and reduced the steady-state level of
Cox2p (Fig. 3C). Both of the growth phenotypes were enhanced when the
incubation temperature was lowered to 16°C and were partially suppressed by increasing the temperature to 36°C (not shown). We also
deleted codons 7 to 14 in a single mutation (cox2-35) (Fig. 3A). This eight-codon deletion mutation allowed nearly
wild-type growth on both nonfermentable medium and minimal medium
lacking arginine. These results demonstrate that codons 2 to 6 are
most important for allowing the translation of downstream sequences. However, since deletion of these codons does not produce a
phenotype as severe as the 13-codon deletion of cox2-20,
codons 7 to 14 also contribute to the action of the putative
positive element. In addition, these results demonstrate that the
leader peptide can be shortened considerably without destroying
pre-Cox2p function.
The
cox2-22 mutation is a compound allele with both a
deletion of codons 7 to 10 (
cox2-23) and the
translationally silent
change of codon 6 from AGA to CGT
(
cox2-29), both of which specify
R (
48).
Neither
cox2-29 alone nor
cox2-23 alone affected
respiratory
growth or arginine prototrophy (Fig.
3A). However, the
combination
of the two alterations in
cox2-22 produced
phenotypes similar
to that of the codons 2-to-6 deletion,
cox2-27, leaky respiratory
and Arg
+ growth at
28°C (Fig.
3A) and reduced Cox2p levels (Fig.
3C).
Both phenotypes
were enhanced by growth at a lower temperature
and suppressed by growth
at higher temperatures (not shown), as
in the case of
cox2-27. The similarity of the
cox2-22 and
cox2-27 phenotypes suggests that both mutations could affect
COX2 translation
by the same mechanism. Interestingly, since
the only difference
between the phenotypically silent codons
7-to-10 deletion (
cox2-23)
and
cox2-22 was
the translationally silent AGA-to-CGT alteration,
these results suggest
that the mRNA sequence could be important
for the function of the
putative positive element, independently
of the leader peptide amino
acid sequence it
encodes.
Suppression of mutations within the leader peptide coding region by
elevated dosage of MRPL36 and PET111.
To further
understand the gene expression defects caused by the cox2-22
and cox2-27 mutations, we screened for nuclear genes that,
when present in a high copy number, would suppress them. The
cox2-22 strain NB64 was transformed with a 2µm vector
genomic library, and plasmids from transformants with increased growth on nonfermentable medium were isolated (see Materials and Methods). We
further analyzed those plasmids which suppressed both
cox2-22 and cox2-27. These plasmids contained a
gene encoding MrpL36p, which had been previously found to copurify with
the large subunit of yeast mitochondrial ribosomes (28). A
subclone containing only MRPL36 retained suppressor activity
for cox2-22 and cox2-27, as well as
cox2-22::ARG8m and
cox2-27::ARG8m (Fig.
4). Since the phenotype caused by the
loss of MrpL36p had not been determined, we deleted the gene (see
Materials and Methods). Cells bearing the
mrpL36
::URA3 allele failed to respire and
became [rho
] and/or
[rho0]. This phenotype is typical of
mutations that block all mitochondrial translation
(34) and is consistent with the idea that MrpL36p could
play a role in translation elongation as part of the large ribosomal
subunit.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 4.
Suppression of the cox2-22 and
cox2-27 mutations in transformants containing multiple
copies of the nuclear genes MRPL36 and PET111.
Strains carrying the cox2-22 or cox2-27 alleles
(NB64 or NB117) as well as the
cox2-22::ARG8m or
cox2-27::ARG8m alleles (NB122 or
NB127) were transformed with the empty vector (YEp352) and
plasmids carrying MRPL36 (pNB107), PET111
(pJM20), or PET111-20 (pJM57), as was indicated (see
Materials and Methods). Transformants were grown as patches on minimal
medium containing arginine (+Arg) and then were replica plated to
nonfermentable medium (YPEG) and minimal medium lacking arginine
( Arg) and incubated at 28°C for 2 or 4 days, respectively.
|
|
We also tested the ability of the
COX2 mRNA-specific
translational activator gene,
PET111, to suppress the
mutations in the
leader peptide coding region. We found that elevated
dosage of
the wild-type
PET111 gene (
39), as
well as a dominant allele
that appears to have increased activity,
PET111-20 (
31), suppressed
cox2-22,
cox2-27, cox2-22::
ARG8m, and
cox2-27::
ARG8m (Fig.
4). Taken
together, these results are consistent with the
idea that the
cox2-22 and
cox2-27 mutations cause similar
translational
defects that can be suppressed by improving the
translation efficiency
either at the level of initiation
(
PET111) or elongation (
MRPL36).
Some intragenic suppressors of cox2-22 and
cox2-27 cause translationally silent alterations in
mRNA sequence that increase translation.
Both the
cox2-22 (NB64) and cox2-27 (NB140) mutant
strains yielded spontaneous pseudorevertants exhibiting
improved respiratory growth. Genetic analysis of 55 cox2-22
pseudorevertants revealed that the slowest growing 23 contained
as-yet-uncharacterized dominant nuclear suppressor mutations, while the
most robust 32 contained mitochondrial mutations (see Materials and
Methods). Eight of the independently isolated mitochondrial
pseudorevertants were further analyzed by DNA sequence
analysis of the 500-bp region of mtDNA surrounding their
COX2 initiation codons. In parallel, 12 robust
independent pseudorevertants of the cox2-27
mutant were also analyzed by sequencing the same region of mtDNA. In
each case, a single base substitution was identified in the coding region specifying the leader peptide or the first three amino acids of
mature Cox2p (Fig. 5A). These intragenic
suppressor mutations fell into three categories: (i) missense
substitutions obtained only as suppressors of either cox2-22
or cox2-27, (ii) missense substitutions obtained as
suppressors of both original mutations (boxed in Fig. 5A), and (iii)
base pair substitutions that do not alter the mutant pre-Cox2p amino
acid sequence, obtained only as suppressors of either
cox2-22 or cox2-27 (circled in Fig. 5A).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of intragenic suppressors of cox2-22
and cox2-27. (A) Nucleotide sequences of mtDNA from the
cox2-22 and cox2-27 mutants, as well as the
indicated pseudorevertants, were determined (see Materials
and Methods). They are aligned with the sequence of the first 18 codons of the wild-type COX2 open reading frame. The
names of the wild-type, mutant, and suppressor alleles are shown with
their deduced amino acid sequences. Only the codons modified by the
intragenic suppressor mutations are shown for those alleles. Deleted
nucleotides are indicated by dots, and nucleotide and/or amino acid
substitutions are in boldface. The SnaBI site created by the
cox2-22 mutation is underlined. Identical suppressor
mutations selected from both the cox2-22 and
cox2-27 mutants are boxed. Nucleotide substitutions that do
not change the encoded amino acid are circled. Multiple independent
isolates of identical suppressor mutations are indicated by names on
the same line. The arrow indicates the leader peptide cleavage site.
(B) Relative steady-state levels of mRNAs and proteins in
cox2-22 and a pseudorevertant strain. For the
top two panels, the COX2 mRNA and 15S rRNA were detected
on the same blot containing RNA from COX2 (NB80),
cox2 (NB40-3C), cox2-22 (NB64), and
cox2-22S8a (NB64S8A) strains by successive hybridization to
COX2 and 15S probes (see Materials and Methods). In the
third panel, 100 µg of total proteins from the same strains used in
the Northern analysis were probed simultaneously with anti-Cox2p and
anti-porin antibodies (both from Molecular Probes, Inc.), as indicated.
For the bottom panel, the strains named above were crossed with the
cox2-60::ARG8m strain NB66 and
diploids were selected on minimal medium supplemented with leucine and
arginine. Samples containing 50 µg of total proteins were prepared
from mitochondrial recombinants and analyzed by Western blotting using
anti-Arg8p antibody.
|
|
Northern analysis of the pseudorevertant carrying the
cox2-22, S8a allele, whose intragenic suppressor is
identical to the
cox2-27 suppressors
S2 and
S9, revealed no change in the steady-state
level of
COX2 mRNA relative to that of the wild type (Fig.
5B).
A
similar result was obtained for the translationally silent
cox2-22 suppressor
S3a (not shown). These results
support the idea that
suppression occurs at the translational
level.
Western blot analyses carried out on the original
pseudorevertants showed that Cox2p accumulation was
restored to wild-type
or nearly wild-type levels in
cox2-22,S8a and other pseudorevertants
of both
cox2-22 and
cox2-27 (Fig.
5B; data not shown). To
monitor
the effect of the suppressor mutations on reporter protein
levels,
cox2-22 was inserted with several of its intragenic
suppressors
into the
cox2::
ARG8m
gene. Pseudorevertants were crossed with a strain (NB66) that
harbors the
cox2-60::
ARG8m allele
(
6), a 130-bp deletion in the fusion construct that
includes the leader peptide coding region. Reporter protein
accumulation
in the resulting diploid recombinants closely mirrored the
strength
of the original haploid suppressors on respiratory medium for
cox2-22,S8a (Fig.
5B) and all other cases tested (data not
shown).
In addition, reporter protein accumulation was similarly
increased
over that directed by the
cox2-27::
ARG8m allele in
recombinant haploid strains derived from the
cox2-27 pseudorevertants by cytoduction (not
shown).
To confirm that the leader peptide mutations and their intragenic
suppressors affected translation rates, we monitored relative
rates of
protein synthesis by pulse labeling cells in the presence
of the
cytoplasmic translation inhibitor cycloheximide and detecting
mitochondrial translation products by autoradiography. The results
confirmed that the rate of Arg8p synthesis directed by the mutant
cox2-27::
ARG8m mRNA was much
lower than that of the wild-type reporter mRNA
(Fig.
6A). The rate of Arg8p synthesis was
restored to various
extents in the pseudorevertants (Fig.
6A), largely consistent
with the relative steady-state levels of Arg8p
observed with the
same strains (not shown).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 6.
Arg8p synthesis is blocked by cox2-27, it was
restored in its pseudorevertants, and it was unaffected by
intragenic suppressor mutations in an otherwise wild-type context.
Mitochondrial translation products were radioactively pulse labeled and
analyzed as described for Fig. 1B. The position of mature Arg8p is
indicated. (A) Arg8p synthesis in the cox2-27
mutant and pseudorevertants
cox2::ARG8m (NB43),
cox2-60::ARG8m (NB54),
cox2-27::ARG8m (NB127),
cox2-27,S1::ARG8m (NAB3),
cox2-27,S2::ARG8m (NAB4),
cox2-27,S4::ARG8m (NAB5),
cox2-27,S6::ARG8m (NAB6),
cox2-27,S7::ARG8m (NAB7),
cox2-27,S12::ARG8m (NAB8), and
cox2-27,S3::ARG8m (NAB9). (B)
Arg8p synthesis in strains bearing only intragenic suppressor
mutations: cox2::ARG8m (NB43),
cox2-60::ARG8m (NB54),
cox2-27::ARG8m (NB127),
cox2-S1::ARG8m (NAB41),
cox2-S2::ARG8m (NAB46),
cox2-S3::ARG8m (NAB45), and
cox2-S4::ARG8m (NAB84).
|
|
To determine whether intragenic suppressor mutations would
affect gene expression when placed in a normal context, we constructed
haploid strains containing four suppressors of
cox2-27 in
otherwise
wild-type
COX2 and
cox2::
ARG8m genes. In no case did
we observe a significant difference from
the wild-type rate of
synthesis of Arg8p (Fig.
6B) or Cox2p (not
shown). Growth phenotypes
and steady state levels of Arg8p and
Cox2p were also wild type in
strains bearing only the suppressor
mutations (not
shown).
The analysis of translation in the
cox2-22 and
cox2-27 mutants and their pseudorevertants
suggests that both original mutations
have similar negative effects on
the rate of mRNA translation
that are alleviated by intragenic
suppressor mutations, some of
which work on both mutations. In
addition, they argue further
that the nucleotide sequence of the
mRNA encoding the leader peptide,
rather than the peptide sequence
itself, strongly influences the
rates of
COX2 translation.
Evidence that a stem structure in the COX2 mRNA
coding region plays a role in regulating translation.
Wild-type
COX2 mRNA is predicted to form a relatively stable
stem-loop structure extending from codon 10 through the first two
bases of codon 17 (Fig.
7A). Similar stems
identical to the top part of the wild-type structure are also predicted
for the cox2-27 mRNA, which lacks codons 2 to 6, and
the compound allele cox2-22 (Fig. 7A). Interestingly, all of
the cox2-27 intragenic suppressors and all but one of the
cox2-22 intragenic suppressors (Fig. 5) affect base pairs in
these predicted stems and would weaken them (Fig. 7A).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 7.
Evidence for a stem-loop structure in the leader
peptide coding region that affects translation. (A)
Predicted secondary structure of the 18 first codons of the wild-type
COX2 mRNA and the corresponding codons of the
cox2-27 and cox2-22 alleles. Structures were
generated for 28°C by using the program mfold 3.0 (http://mfold2.wustl.edu/~mfold/rna/form1-2.3.cgi) with default
parameters (29, 59). Similar structures of this region
were obtained when folding extended mRNA fragments including the 18 first codons. The initiation codon in each sequence is boxed.
Arrows indicate the pre-Cox2p cleavage site position in the
encoded polypeptide. Black dots indicate G:C base pairs and grey
dots indicate weaker A:U or G:U base pairs. The nucleotide
substitutions found in the various cox2-27 and
cox2-22 pseudorevertants (Fig. 5) are
marked. The cox2-23 allele is also shown on the
cox2-22 structure since it can be viewed as an
intragenic suppressor of cox2-22 with two
substitutions. (B) Phenotypic effects of mutations in the stem
structure of the cox2-27 mRNAs. Diploid
recombinant cells carrying the indicated alleles were replicated
on minimal SD medium lacking arginine ( Arg) and nonfermentable
medium (YPEG) and were incubated at 28°C for 2 and 3 days,
respectively. The diploid cells were selected for complementing
nutritional markers on minimal SD medium containing arginine after
mating strains containing the following alleles with the
cox2-60::ARG8m strain NB54
(lacking nucleotides 63 to +66): cox2-27, NB140;
cox2-27, S7, NB140S7; cox2-27, S12,
NB140S12; cox2-27, S7, S12, NB241 for growth on YPEG medium
and NB242 for growth on medium lacking arginine.
|
|
To test the possible significance of the stem, we constructed triple
mutants that restored potential base pairing downstream
of the
cox2-27 mutation by compensating for several suppressor
substitutions. We then examined the effects of the compensating
mutations on the expression of the
cox2::
ARG8m reporter and
COX2. For example, a single predicted U:A base pair
was
disrupted by suppressors
S12 (U to G) and
S7 (A
to C), each
of which improved the expression of the
cox2-27::
ARG8m reporter (Fig.
7).
However, when
S12 and
S7 were placed together
in
the same mRNA, generating a stronger predicted G:C base pair
in the
stem, reporter expression and respiratory growth were greatly
decreased, to a level below that of
cox2-27 alone (Fig.
7B).
We
observed similar decreases in reporter expression when we tested
mutations that restored pairing to the predicted base pair disrupted
by
both
cox2-27 suppressors
S1 and
S4
(not shown). Disruption
of this predicted base pair by combining the
S1- and
S4-compensating
mutations in one mRNA
increased reporter expression, as expected
(not shown). Similarly, the
addition of the
S6 suppressor substitution
to an mRNA
containing
S4 and the
S4-compensating mutation
also
increased reporter expression, as expected (not shown). These
data
strongly support the in vivo existence of the predicted stem
and
indicate that its stability plays a role in controlling
COX2 mRNA
translation.
Nucleotide sequence in the mRNA encoding the leader peptide is
critical for COX2 translation, while the leader peptide
amino acid sequence is not highly constrained.
Several results
described above suggest that elements in the leader peptide coding
region, critical for translation in the context of downstream
COX2 codons, are defined at the level of nucleotide
sequence rather than amino acid sequence. To investigate this
possibility further, we shifted the reading frame in this region to +1
by inserting a single nucleotide at upstream positions and deleting a
single nucleotide at downstream positions in both the complete leader
peptide coding region and a functional construct with deleted
codons 7 to 14 (cox2-35) (Fig.
8). These frameshifts caused wholesale
changes in the sequence of the leader peptide, while minimally
modifying the mRNA sequence. Surprisingly, all of these frameshift
mutations, including cox2-39 (which lacks codons 7 to
14), behaved like the wild type for both respiratory growth and
Arg+ prototrophy when placed in the COX2 and
cox2::ARG8m genes, respectively
(Fig. 8).

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 8.
Shifting the reading frame to +1 in the leader peptide
coding region has no effect on respiratory growth or arginine
prototrophy. Control strains and strains carrying the indicated
frameshift alleles in the COX2 leader peptide coding region
were patched on complete glucose medium and replica plated on
nonfermentable medium (YPEG) for alleles inserted in the plain
COX2 gene and on minimal medium lacking arginine ( Arg) or
containing arginine (+Arg) for alleles inserted in the reporter
construct. Photographs were taken after a 2-day incubation at 28°C.
+, addition of an A nucleotide; for cox2-36, cox2-38, and
cox2-39, this is immediately following the initiation
codon, and for cox2-37, it is immediately following the
sixth codon. , deletion of the G nucleotide immediately before
wild-type codon 15 in cox2-36 and cox2-37 and
of the A nucleotide immediately before wild-type codon 7 in
cox2-38 and cox2-39. Deleted amino acids are
shown by dots, and modified amino acids are in bold letters. The arrow
marks the leader peptide cleavage site. Alleles and strains (for
COX2 and for
cox2::ARG8m, respectively) were
as follows: COX2 (NB80 and NB43), cox2-20
(NB58 and NB120), cox2-36 (NB173 and NB136),
cox2-37 (NB174 and NB137), cox2-38 (NB175 and
NB138), and cox2-39 (NB176 and NB139).
|
|
We conclude that the RNA sequence is clearly more important for
translation in this context than the leader peptide amino
acid
sequence. Furthermore, membrane insertion, export of N-tail
and C-tail
domains and assembly of cytochrome oxidase can all
be achieved with a
pre-Cox2p leader peptide sequence that is very
different from that of
the wild type. However, it is important
to note that in this context,
the charge and hydrophobicity characteristics
of the leader peptides
generated by these +1 frameshifts are similar
to those of the wild
type. Thus, one could not exclude functional
constraints on the leader
peptide amino acid sequence on the basis
of these
data.
If mRNA sequence in the leader peptide region plays a greater
functional role than the amino acid sequence, then multiple
synonymous
nucleotide changes in the region should affect gene
expression. We made
six such silent mutations in the first six
codons of the functional
construct with codons 7 to 14 (
cox2-35)
deleted to
generate the
cox2-41 mutation (Fig.
9). In contrast
to the corresponding
frameshift mutation described above (
cox2-39),
cox2-41 abolished both respiratory growth and growth in the
absence
of arginine when placed in the
COX2 and
cox2::
ARG8m genes, respectively
(Fig.
9). This mutation had no effect on
mRNA levels (Fig.
9B), but
prevented accumulation of their protein
products (Fig.
9C). Thus,
changes in the
cox2-41 mRNA sequence
abolished
translation despite the fact that this allele specifies
a functional
leader peptide amino acid sequence.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 9.
Effects of silent substitutions and shifting the reading
frame to 1 in the first six codons of a leader peptide coding
region lacking codons 7 to 14. (A) Allele names, their nucleotide
sequences and predicted amino acid sequences are shown on the left. All
are derived from the functional allele cox2-35, which
carries a deletion of codons 7 to 14 indicated by the kinked line
(Fig. 3). Altered nucleotides and amino acids are shown in bold
letters. , deletion of two T nucleotides and addition of an A
nucleotide in the DNA sequence; +, addition of a T nucleotide in
cox2-43. The two codons further deleted in
cox2-43R1 are indicated by dots. The long arrow indicates
the origin of cox43R1 as a spontaneous
pseudorevertant of cox2-43. The short arrow
indicates the leader peptide cleavage site. On the right, strains
carrying the indicated versions of the COX2 leader peptide
coding region were patched on complete glucose medium and replica
plated on nonfermentable medium (YPEG) or glucose medium (YPD) for
alleles inserted in the COX2 gene (left panel) and on
minimal medium lacking arginine ( Arg) or containing arginine (+Arg)
for alleles inserted in the
cox2::ARG8m construct (right
panel). Plates were incubated at 16, 28, or 36°C as indicated and
were photographed after 1- to 10-day incubations, depending on the
medium and temperature. Strains were (for COX2 and for
cox2::ARG8m, respectively)
COX2, NB80 and NB43; cox2-35, NB172 and NB135;
cox2, NB97 and NB54; cox2-41, NB177 and NB179;
cox2-43, NB178 and NB181; cox2-43R1, NB178R1 and
a diploid recombinant from the cross of NB178R1 × NB66. (B)
Relative steady-state levels of mutant mRNAs were determined by
Northern blot analysis of total RNAs from the indicated strains (as for
panel A), which were hybridized simultaneously to the COX2
and cox2::ARG8m probes and were
reprobed with the 15S rRNA probe (see Materials and Methods). (C)
Relative steady-state levels of Cox2p and Arg8p in cells grown at 28 or
36°C were determined by Western blot analysis. Samples with 200 µg
of total proteins from the indicated strains (as in panel A), which
were grown at the indicated temperatures, were probed with either
anti-Arg8p or anti-Cox2p and anti-porin antibodies (all from Molecular
Probes, Inc.) as indicated. The COX2 panel was overexposed
to reveal low levels of Cox2p in the cox2-43 mutant grown at
36°C.
|
|
The leader peptide amino acid sequence appears to have a role in
cytochrome oxidase assembly that is at least partially distinct from
the translational role of the mRNA encoding it.
We were unable
to simply shift the leader peptide reading frame to
1 due to the
occurrence of stop codons in that frame. However, we constructed a
compound allele termed cox2-43, which was derived from the
functional construct with a deletion of codons 7 to 14 (cox2-35), that was translated in the
1 frame: an upstream nucleotide was deleted, a downstream nucleotide was inserted, and two
nucleotide substitutions were made to eliminate the resulting stop
codons (Fig. 9A). These changes significantly altered the mRNA
sequence and dramatically changed the character of the amino acid sequence.
This compound allele,
cox2-43, had little or no effect on
the level of
COX2 mRNA (Fig.
9B), but prevented
detectable Cox2p
accumulation in cells grown at 28°C (Fig.
9C). In
cox2-43 cells
grown at 36°C, there was a low but
detectable accumulation of
Cox2p, possibly in its precursor form (Fig.
9C), demonstrating
that this mRNA is partially translatable.
However, this mutation
abolished respiratory growth at all three
temperatures tested
(Fig.
9A), suggesting that the mutant form of
pre-Cox2p made in
the
cox2-43 mutant at 36°C is not
functional. Interestingly, a
strain bearing the
cox2-43::
ARG8m construct
exhibited weak but significant growth on medium lacking
arginine and
contained easily detectable levels of Arg8p when
grown at 36°C,
confirming that this leader peptide mRNA sequence
was partially
competent in supporting translation at that temperature
(Fig.
9A and
C). Furthermore, the presence of
PET111-20 on a
high-copy-number
plasmid greatly improved the growth of a
cox2-43::
ARG8m strain in the
absence of arginine at 36°C, but had no effect
on the respiratory
deficiency of a
cox2-43 strain (not shown).
In this context,
it is important to note that it was previously
found that low levels of
Cox2p synthesis can be sufficient for
detectable respiratory growth
(
31), while comparably low levels
of Arg8p synthesis are
insufficient for Arg
+ growth (
6).
Of all the mutations constructed in this study,
cox2-43 is
the only one that is competent for translation, albeit only at
an
elevated temperature, but encodes a nonfunctional form of pre-Cox2p.
Thus, while the pre-Cox2p leader peptide amino acid sequence can
be
altered substantially without destroying function, it nevertheless
appears to play a role in assembly of cytochrome oxidase at a
step
downstream of translation, and some amino acid sequences
are
incompatible with this role, at least at 36°C.
The
cox2-43 mutant strain yielded spontaneous respiring
pseudorevertants. We determined the mtDNA sequence in
this region
for three independent pseudorevertants that
exhibited strong respiratory
growth at all temperatures. All three
contained identical deletions
of the two codons immediately
preceding the leader peptide cleavage
site, as shown for
cox2-43R1 (Fig.
9A). The
cox2-43R1 allele
supported
wild-type respiratory growth (Fig.
9A) and wild-type levels
of
Cox2p (not shown). A strain bearing the
cox2-43R1::
ARG8m reporter
construct grew well on medium lacking arginine at all
temperatures
(Fig.
9A). Thus, this two-codon deletion generated
both an mRNA
sequence exhibiting improved translation relative
to
cox2-43
and a leader peptide amino acid sequence that supports
cytochrome
oxidase
assembly.
 |
DISCUSSION |
Leader peptides on precursors of proteins inserted into membranes,
or translocated through them, consist of amino acids sequences that
generally play a role in protein targeting. However, the nucleotides
encoding them are not typically involved in the regulation of precursor
synthesis. In this study, we explored genetically the function of the
15-amino-acid pre-Cox2p leader peptide and the mRNA encoding it,
specified by S. cerevisiae mtDNA. We examined the
effects of mutations on the synthesis and function of pre-Cox2p and on
the synthesis of a reporter protein, Arg8p, whose coding sequence was
translationally fused to COX2 codon 91. Our data clearly
demonstrate that the translation of the COX2 mRNA
depends upon the mRNA sequence of codons specifying the
pre-Cox2p leader peptide, in addition to its previously known
dependence upon mRNA-specific translational activation by
Pet111p through the 5'-UTL (17, 31).
First, we found that deletion of 13 leader peptide codons (2 to 14)
from the cox2::ARG8m reporter
mRNA prevented synthesis of the reporter protein despite normal
mRNA levels. However, ARG8m was expressed
from the COX2 locus in the complete absence of any
COX2 codons. These findings strongly suggest that the
first 91 codons of the pre-Cox2p coding sequence contain
antagonistic elements that control translation positively and
negatively: the positively acting element includes sequences in the
first 14 codons specifying the leader peptide, while the negatively
acting element appears to be within codons 15 to 91.
Our further analysis of mutations within the leader peptide coding
sequence indicates that the positively acting element is complex or
multipartite. None of the smaller deletion mutations we made in this
region produced phenotypes as strongly negative as the deletion of
codons 2 to 14 (cox2-20). Deletion of codons 2 to 6 (cox2-27) caused both leaky respiratory and leaky
Arg
phenotypes without affecting mRNA levels,
demonstrating the importance of this region for translation. However,
residual growth of the cox2-27 and
cox2-27::ARG8m strains indicates
that the leader peptide codons remaining in this mutation,
codons 7 to 14, also have a positive effect on translation in the
absence of codons 2 to 6.
The positively acting element embedded in the leader peptide coding
sequence functions at the level of nucleotide sequence, not amino acid
sequence, since a shift of the reading frame through this region left
the mRNA sequence relatively untouched while changing the amino
acid sequence and did not detectably affect translation. On the other
hand, when we altered the mRNA sequence of codons 2 to 6 (in
the absence of codons 7 to 13) without changing the amino acid
sequence they encoded (cox2-41), we completely eliminated
translation. In this connection, it is noteworthy that the first six
codons contain an 11-base sequence (AGAUUUAUUAA) that is
also present one base upstream of the initiation codon in the
COX2 5'-UTL. It is tempting to speculate that the striking direct repeat of these bases plays a role in the positive regulatory function of the first six codons. The repeats could also play a
role in the stringent selection of the COX2 initiation site, which they bracket. The ARG8m coding region
lacks this sequence, yet is efficiently expressed in the absence of
COX2 codons, indicating that repetition of this sequence
in the coding region is not essential for general translation initiation or elongation. However, the sequence repeat could be important for antagonizing the negative element in downstream COX2 codons. A mutation altering the upstream copy of
the sequence repeat in the 5'-UTL had a modest negative effect on
COX2 expression (11) and greatly reduced
cox2::ARG8m expression (N. Bonnefoy, unpublished data), consistent with this possibility.
Two different but overlapping mutations in the leader peptide coding
region behave similarly, suggesting that they affect the same
mechanism. Translation of the
cox2::ARG8m reporter was reduced
to a similar degree both by deletion of codons 2 to 6 (cox2-27) and by a compound allele in which codon 6 was
changed from AGA to CGU (both encoding R), and codons 7 to 10 (cox2-22) were deleted. Both of these alleles were
suppressed by nucleotide substitutions clustered in the downstream part
of the leader peptide coding region and, in the case of
cox2-22, the first three codons specifying mature Cox2p.
Interestingly, we selected two different missense substitutions
affecting codon 11 as suppressors of both cox2-27 and
cox2-22, supporting the idea that the two original mutations
impaired translation by a similar mechanism. In addition, some
intragenic suppressors of each of the mutations were silent
third-position substitutions in the COX2 coding sequence,
consistent with our other data showing the importance of
nucleotide sequence.
Similar stem-loop structures are predicted for the COX2
mRNAs of the wild type, cox2-27, and cox2-22
in the sequence corresponding to wild-type codons 10 through 17. This stem appears to exist in vivo and to play a role in reducing the
translation of the mutant mRNAs, since all but one of the
intragenic suppressors of these mutations that increased translation
also weakened the stem. Furthermore, translation was reduced by
compensating site-directed mutations that restored pairing with
cox2-27 suppressor substitutions. Indeed, generation of a
more stable stem, by conversion of a U:A base pair to G:C, reduced
expression to a level below that of cox2-27. These results
demonstrate that unfolding of the stem is necessary to improve
translation of downstream coding sequences in the absence of codons
2 to 6. One possible interpretation of these data is that the residual
positively acting sequences in codons 7 to 14 must be unfolded to
function in the absence of codons 2 to 6. An alternative
interpretation is that in the absence of codons 2 to 6, a
stable stem could strengthen the action of the negative element
downstream of codon 14 (this stem-loop cannot solely comprise
the negative element since cox2-27 mRNAs are translated better than cox2-20 and cox2-41 mRNAs
which lack it). These are not mutually exclusive possibilities,
considering the potential dynamics of mRNA structure during translation.
We identified two nuclear genes, PET111 and
MRPL36, as dosage-dependent suppressors of
cox2-27 and cox2-22. Pet111p is the COX2 mRNA-specific translational activator (32,
39, 51), a rate-limiting factor in COX2
expression (17). Elevated Pet111p activity can also
suppress mutations in both the mRNA 5'-UTL (31) and the initiation codon (6). Since a fraction of
ribosomes are able to pass the leaky translational blocks caused by the cox2-27 and cox2-22 mutations, increased
initiation would be expected to improve gene expression.
MrpL36p was previously found to be associated with mitochondrial
ribosomal large subunits (28), suggesting that it may
function during translation elongation. This protein, which we found to be essential for global mitochondrial gene expression, contains a
central 80-residue region exhibiting recognizable similarity to
the entire length of the bacterial L31 family of ribosomal proteins in
a PSI-BLAST comparison. Little is known about L31, except that it
is loosely associated with the large subunit of Escheridria
coli ribosomes (12). Loose ribosomal association of
MrpL36p could account for the unexpected isolation of a
dosage-dependent suppressor encoding a component of the ribosome.
Flanking the central L31-like region is a roughly 60-residue N-terminal
sequence exhibiting no similarities to known proteins and a 60-residue C-terminal region with weak but nevertheless intriguing similarity in a
PSI-BLAST analysis to a short region of E. coli Ffh, a
protein subunit of the signal recognition particle. This region of
similarity lies within the Ffh M domain, which binds to both the 4.5S
RNA and the signal sequence of membrane proteins (16).
Thus, one could speculate that MrpL36p might mediate regulatory
interactions among the elongating ribosome, positive and negative
elements in the COX2 mRNA coding sequence, and the
nascent pre-Cox2p polypeptide to coordinate synthesis and translocation
of the pre-Cox2p N-tail domain through the inner membrane.
The role of the pre-Cox2p leader peptide amino acid sequence in
controlling synthesis and membrane insertion of the protein remains
enigmatic. The leader peptide sequences from several fungal and plant
species are not strongly conserved (20, 25), and animal
forms of Cox2p lack it entirely. While a previous study indicated that
the leader peptide causes membrane association of a passenger protein
(21), our present findings demonstrate that several amino
acid sequences, which were generated by frameshifts and various peptide
lengths, can effectively carry out this and/or any other steps
necessary for cytochrome oxidase assembly. For example, while the
wild-type leader peptide is 15 residues long with an acidic group at
the third position, we observed normal Cox2p accumulation and
respiratory growth in a strain whose frameshifted leader peptide is 5 residues long, lacks an acidic group, and has a basic group at the
second position (cox2-43R1).
Nevertheless, our genetic analysis indicates that the leader peptide
amino acid sequence is not completely unconstrained with respect to
function in cytochrome oxidase assembly. One allele, cox2-43, allowed synthesis of the reporter protein and Cox2p
at reduced rates, but prevented Cox2p from assembling into active cytochrome oxidase. The leader peptide encoded by cox2-43 is
strikingly different from the wild type and the other functional
sequences we generated, in that it has positively and negatively
charged residues (KD) just upstream of the processing site. Spontaneous pseudorevertants of cox2-43 all had identical
deletions of the six bases encoding these charged residues, which
allowed efficient cytochrome oxidase assembly and greatly improved
translation of the reporter protein. It is striking that the
pseudorevertant encoding an active form of pre-Cox2p also
increased mRNA translation.
We propose that the positive and negative translational regulatory
elements specified within the first 91 codons of COX2
could function to ensure that continued translation of the mRNA
occurs only if the nascent N terminus has successfully begun the
process of membrane insertion leading to cytochrome oxidase assembly. While we cannot yet present a detailed model for how this feedback control mechanism might work, MrpL36p and Pet111p could function to
convey information about the state of the nascent pre-Cox2p N terminus
to the translating ribosome at the point where it encounters the
negative element. We have also isolated dominant nuclear suppressors of
both leader peptide mutations cox2-22 and
cox2-27, which may identify other components of this system
and lead to a better understanding of its mechanism. Passage through
this element is likely to involve a dynamic interplay between
alternative mRNA secondary structures and bound proteins.
Similar assembly feedback regulation of ATP synthase biogenesis could
operate via pre-Atp6p, the only other yeast mitochondrial gene product
with a leader peptide (30, 55). Such systems would
resemble other translational feedback regulatory loops that couple the
synthesis of specific components to the assembly of complexes. For
example, translation of the chloroplast mRNA encoding cytochrome
f is coupled to assembly of the cytochrome
b6/f complex in Chlamydomonas
(9, 57). In Caulobacter, translation of the
flagellin fljK mRNA is regulated by assembly of the
basal body-hook structure (1). In this case, in which the
flagellin is transported out of the cell by a type III secretion
system, the regulation of fljK translation depends on
sequences in both the fljK mRNA 5'-UTL and the first 9 codons of the structural gene. Finally, in the type III secretion
system of Yersinia, signals necessary for both the
translation and the secretion of Yop proteins have been mapped to the
first 15 codons and shown to function at the level of nucleotide
sequence rather than amino acid sequence (2). Thus, the
regulatory system revealed by this study is likely to have its origins
in the bacterial ancestors of mitochondria.
 |
ACKNOWLEDGMENTS |
We are grateful to Geneviève Dujardin and Thomas L. Mason
for supplying antibodies.
N.B. was a Human Frontier Science Program Organization long-term fellow
(LT22/96) during the early stages of this work and is currently
supported by the Association Française contre les Myopathies. This work has been supported by an NIH research
grant (GM29362) to T.D.F.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Genetics, Cornell University, Ithaca, NY
14853-2703. Phone: (607) 254-4835. Fax: (607) 255-6249. E-mail:
tdf1{at}cornell.edu.
 |
REFERENCES |
| 1.
|
Anderson, D. K., and A. Newton.
1997.
Posttranscriptional regulation of Caulobacter flagellin genes by a late flagellum assembly checkpoint.
J. Bacteriol.
179:2281-2288[Abstract/Free Full Text].
|
| 2.
|
Anderson, D. M., and O. Schneewind.
1997.
A mRNA signal for the type III secretion of Yop proteins by Yersinia enterocolitica.
Science
278:1140-1143[Abstract/Free Full Text].
|
| 3.
|
Anderson, S.,
M. H. L. De Bruijn,
A. R. Coulson,
I. C. Eperon,
F. Sanger, and I. G. Young.
1982.
Complete sequence of bovine mitochondrial DNA: conserved features of the mammalian mitochondrial genome.
J. Mol. Biol.
156:683-717[CrossRef][Medline].
|
| 4.
|
Behrens, M.,
G. Michaelis, and E. Pratje.
1991.
Mitochondrial inner membrane protease 1 of Saccharomyces cerevisiae shows sequence similarity to the Escherichia coli leader peptidase.
Mol. Gen. Genet.
228:167-176[CrossRef][Medline].
|
| 5.
|
Bonnefoy, N.,
F. Chalvet,
P. Hamel,
P. P. Slonimski, and G. Dujardin.
1994.
OXA1, a Saccharomyces cerevisiae nuclear gene whose sequence is conserved from prokaryotes to eukaryotes controls cytochrome oxidase biogenesis.
J. Mol. Biol.
239:201-212[CrossRef][Medline].
|
| 6.
|
Bonnefoy, N., and T. D. Fox.
2000.
In vivo analysis of mutated initiation codons in the mitochondrial COX2 gene of Saccharomyces cerevisiae fused to the reporter gene ARG8m reveals lack of downstream reinitiation.
Mol. Gen. Genet.
262:1036-1046[CrossRef][Medline].
|
| 7.
|
Bonnefoy, N., and T. D. Fox.
2001.
Genetic transformation of Saccharomyces cerevisiae mitochondria.
Methods Cell Biol.
65:381-396[Medline].
|
| 8.
|
Chen, D. C.,
B. C. Yang, and T. T. Kuo.
1992.
One-step transformation of yeast in stationary phase.
Curr. Genet.
21:83-84[CrossRef][Medline].
|
| 9.
|
Choquet, Y.,
D. B. Stern,
K. Wostrikoff,
R. Kuras,
J. Girard-Bascou, and F. A. Wollman.
1998.
Translation of cytochrome f is autoregulated through the 5' untranslated region of petA mRNA in Chlamydomonas chloroplasts.
Proc. Natl. Acad. Sci. USA
95:4380-4385[Abstract/Free Full Text].
|
| 10.
|
Costanzo, M. C.,
N. Bonnefoy,
E. H. Williams,
G. D. Clark-Walker, and T. D. Fox.
2000.
Highly diverged homologs of Saccharomyces cerevisiae mitochondrial mRNA-specific translational activators have orthologous functions in other budding yeasts.
Genetics
154:999-1012[Abstract/Free Full Text].
|
| 11.
|
Dunstan, H. M.,
N. S. Green-Willms, and T. D. Fox.
1997.
In vivo analysis of Saccharomyces cerevisiae COX2 mRNA 5'-untranslated leader functions in mitochondrial translation initiation and translational activation.
Genetics
147:87-100[Abstract].
|
| 12.
|
Eistetter, A. J.,
P. D. Butler,
R. R. Traut, and T. G. Fanning.
1999.
Characterization of Escherichia coli 50S ribosomal protein L31.
FEMS Microbiol. Lett.
180:345-349[CrossRef][Medline].
|
| 13.
|
Folley, L. S., and T. D. Fox.
1991.
Site-directed mutagenesis of a Saccharomyces cerevisiae mitochondrial translation initiation codon.
Genetics
129:659-668[Abstract].
|
| 14.
|
Fox, T. D.
1996.
Genetics of mitochondrial translation, p. 733-758.
In
J. W. B. Hershey, M. B. Matthews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
|
| 15.
|
Fox, T. D.,
L. S. Folley,
J. J. Mulero,
T. W. McMullin,
P. E. Thorsness,
L. O. Hedin, and M. C. Costanzo.
1991.
Analysis and manipulation of yeast mitochondrial genes.
Methods Enzymol.
194:149-165[Medline].
|
| 16.
|
Freymann, D. M.,
R. J. Keenan,
R. M. Stroud, and P. Walter.
1997.
Structure of the conserved GTPase domain of the signal recognition particle.
Nature
385:361-364[CrossRef][Medline].
|
| 17.
| Green-Willms, N. S., C. A. Butler, H. M. Dunstan, and T. D. Fox. Pet111p, an inner membrane-bound
translational activator that limits expression of the
Saccharomyces cerevisiae mitochondrial gene COX2.
J. Biol. Chem., in press.
|
| 18.
|
Grivell, L. A.
1995.
Nucleo-mitochondrial interactions in mitochondrial gene expression.
Crit. Rev. Biochem. Mol. Biol.
30:121-164[Medline].
|
| 19.
|
Grivell, L. A.,
M. Artal-Sanz,
G. Hakkaart,
L. de Jong,
L. G. Nijtmans,
K. van Oosterum,
M. Siep, and H. van der Spek.
1999.
Mitochondrial assembly in yeast.
FEBS Lett.
452:57-60[CrossRef][Medline].
|
| 20.
|
Hardy, C. M., and G. D. Clark-Walker.
1990.
Nucleotide sequence of the cytochrome oxidase subunit 2 and Val-tRNA genes and surrounding sequences from Kluyveromyces lactis K8 mitochondrial DNA.
Yeast
6:403-410[CrossRef][Medline].
|
| 21.
|
He, S., and T. D. Fox.
1997.
Membrane translocation of mitochondrially coded Cox2p: distinct requirements for export of amino- and carboxy-termini, and dependence on the conserved protein Oxalp.
Mol. Biol. Cell
8:1449-1460[Abstract].
|
| 22.
|
Hell, K.,
J. Herrmann,
E. Pratje,
W. Neupert, and R. A. Stuart.
1997.
Oxa1p mediates the export of the N- and C-termini of pCoxII from the mitochondrial matrix to the intermembrane space.
FEBS Lett.
418:367-370[CrossRef][Medline].
|
| 23.
|
Hill, J. E.,
A. M. Myers,
T. J. Koerner, and A. Tzagoloff.
1986.
Yeast/E. coli shuttle vectors with multiple unique restriction sites.
Yeast
2:163-167[CrossRef][Medline].
|
| 24.
|
Ho, S. N.,
H. D. Hunt,
R. M. Horton,
J. K. Pullen, and L. R. Pease.
1989.
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
Gene
77:51-59[CrossRef][Medline].
|
| 25.
|
Hoeben, P.,
G. Weiller, and G. D. Clark-Walker.
1993.
Larger rearranged mitochondrial genomes in Dekkera/Brettanomyces yeasts are more closely related than smaller genomes with a conserved gene order.
J. Mol. Evol.
36:263-269[CrossRef][Medline].
|
| 26.
|
Johnston, S. A.,
P. Q. Anziano,
K. Shark,
J. C. Sanford, and R. A. Butow.
1988.
Mitochondrial transformation in yeast by bombardment with microprojectiles.
Science
240:1538-1541[Abstract/Free Full Text].
|
| 27.
|
Kermorgant, M.,
N. Bonnefoy, and G. Dujardin.
1997.
Oxa1p, which is required for cytochrome c oxidase and ATP synthase complex formation, is embedded in the mitochondrial inner membrane.
Curr. Genet.
31:302-307[CrossRef][Medline].
|
| 28.
|
Kitakawa, M.,
H.-R. Graack,
L. Grohmann,
S. Goldschmidt-Reisin,
E. Herfurth,
B. Wittmann-Liebold,
T. Nishimura, and K. Isono.
1997.
Identification and characterization of genes for mitochondrial ribosomal proteins of Saccharomyces cerevisiae.
Eur. J. Biochem.
245:449-456[Medline].
|
| 29.
|
Mathews, D. H.,
J. Sabina,
M. Zuker, and D. H. Turner.
1999.
Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure.
J. Mol. Biol.
288:911-940[CrossRef][Medline].
|
| 30.
|
Michon, T.,
M. Galante, and J. Velours.
1988.
NH2-terminal sequence of the isolated yeast ATP synthase subunit 6 reveals post-translational cleavage.
Eur. J. Biochem.
172:621-625[Medline].
|
| 31.
|
Mulero, J. J., and T. D. Fox.
1993.
Alteration of the Saccharomyces cerevisiae COX2 5'-untranslated leader by mitochondrial gene replacement and functional interaction with the translational activator protein PET111.
Mol. Biol. Cell
4:1327-1335[Abstract].
|
| 32.
|
Mulero, J. J., and T. D. Fox.
1993.
PET111 acts in the 5'-leader of the Saccharomyces cerevisiae mitochondrial COX2 mRNA to promote its translation.
Genetics
133:509-516[Abstract].
|
| 33.
|
Mulero, J. J., and T. D. Fox.
1994.
Reduced but accurate translation from a mutant AUA initiation codon in the mitochondrial COX2 mRNA of Saccharomyces cerevisiae.
Mol. Gen. Genet.
242:383-390[Medline].
|
| 34.
|
Myers, A. M.,
L. K. Pape, and A. Tzagoloff.
1985.
Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae.
EMBO J.
4:2087-2092[Medline].
|
| 35.
|
Nasmyth, K. A., and K. Tatchell.
1980.
The structure of transposable yeast mating type loci.
Cell
19:753-764[CrossRef][Medline].
|
| 36.
|
Neff, N. F.,
J. H. Thomas,
P. Grisafi, and D. Botstein.
1983.
Isolation of the -tubulin gene from yeast and demonstration of its essential function in vivo.
Cell
33:211-219[CrossRef][Medline].
|
| 37.
|
Nunnari, J.,
T. D. Fox, and P. Walter.
1993.
A mitochondrial protease with two catalytic subunits of nonoverlapping specificities.
Science
262:1997-2004[Abstract/Free Full Text].
|
| 38.
|
Pinkham, J. L.,
A. M. Dudley, and T. L. Mason.
1994.
T7 RNA polymerase-dependent expression of COXII in yeast mitochondria.
Mol. Cell. Biol.
14:4643-4652[Abstract/Free Full Text].
|
| 39.
|
Poutre, C. G., and T. D. Fox.
1987.
PET111, a Saccharomyces cerevisiae nuclear gene required for translation of the mitochondrial mRNA encoding cytochrome c oxidase subunit II.
Genetics
115:637-647[Abstract/Free Full Text].
|
| 40.
|
Poyton, R. O.,
D. M. J. Duhl, and G. H. D. Clarkson.
1992.
Protein export from the mitochondrial matrix.
Trends Cell Biol.
2:369-375[CrossRef][Medline].
|
| 41.
|
Pratje, E.,
G. Mannhaupt,
G. Michaelis, and K. Beyreuther.
1983.
A nuclear mutation prevents processing of a mitochondrially encoded membrane protein in Saccharomyces cerevisiae.
EMBO J.
2:1049-1054[Medline].
|
| 42.
|
Rose, M. D.,
F. Winston, and P. Hieter.
1988.
Methods in yeast genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 43.
|
Sanchirico, M. E.,
T. D. Fox, and T. L. Mason.
1998.
Accumulation of mitochondrially synthesized Saccharomyces cerevisiae Cox2p and Cox3p depends on targeting information in untranslated portions of their mRNAs.
EMBO J.
17:5796-5804[CrossRef][Medline].
|
| 44.
|
Schneider, A.,
M. Behrens,
P. Scherer,
E. Pratje,
G. Michaelis, and G. Schatz.
1991.
Inner membrane protease I, an enzyme mediating intramitochondrial protein sorting in yeast.
EMBO J.
10:247-254[Medline].
|
| 45.
|
Seraphin, B., and S. Kandels-Lewis.
1996.
An efficient PCR mutagenesis strategy without gel purification step that is amenable to automation.
Nucleic Acids Res.
24:3276-3277[Abstract/Free Full Text].
|
| 46.
|
Sevarino, K. A., and R. O. Poyton.
1980.
Mitochondrial biogenesis: identification of a precursor to yeast cytochrome c oxidase subunit II, an integral polypeptide.
Proc. Natl. Acad. Sci. USA
77:142-146[Abstract/Free Full Text].
|
| 47.
|
Shen, Z., and T. D. Fox.
1989.
Substitution of an invariant nucleotide at the base of the highly conserved "530-loop" of 15S rRNA causes suppression of mitochondrial ochre mutations.
Nucleic Acids Res.
17:4535-4539[Abstract/Free Full Text].
|
| 48.
|
Sibler, A. P.,
G. Dirheimer, and R. P. Martin.
1986.
Codon reading patterns in Saccharomyces cerevisiae mitochondria based on sequences of mitochondrial tRNAs.
FEBS Lett.
194:131-138[CrossRef][Medline].
|
| 49.
|
Steele, D. F.,
C. A. Butler, and T. D. Fox.
1996.
Expression of a recoded nuclear gene inserted into yeast mitochondrial DNA is limited by mRNA-specific translational activation.
Proc. Natl. Acad. Sci. USA
93:5253-5257[Abstract/Free Full Text].
|
| 50.
|
Steffens, G. J., and G. Buse.
1979.
Studies on cytochrome c oxidase (IV): primary structure and function of subunit II.
Hoppe-Seyler's Z. Physiol. Chem.
360:613-619[Medline].
|
| 51.
|
Strick, C. A., and T. D. Fox.
1987.
Saccharomyces cerevisiae positive regulatory gene PET111 encodes a mitochondrial protein that is translated from an mRNA with a long 5' leader.
Mol. Cell. Biol.
7:2728-2734[Abstract/Free Full Text].
|
| 52.
|
Tian, G. L.,
C. Macadre,
A. Kruszewska,
B. Szczesniak,
A. Ragnini,
P. Grisanti,
T. Rinaldi,
C. Palleschi,
L. Frontali,
P. P. Slonimski, and J. Lazowska.
1991.
Incipient mitochondrial evolution in yeasts. I. The physical map and gene order of Saccharomyces douglasii mitochondrial DNA discloses a translocation of a segment of 15,000 base-pairs and the presence of new introns in comparison with Saccharomyces cerevisiae.
J. Mol. Biol.
218:735-746[CrossRef][Medline].
|
| 53.
|
Torello, A. T.,
M. H. Overholzer,
V. L. Cameron,
N. Bonnefoy, and T. D. Fox.
1997.
Deletion of the leader peptide of the mitochondrially encoded precursor of Saccharomyces cerevisiae cytochrome c oxidase subunit II.
Genetics
145:903-910[Abstract].
|
| 54.
|
Tzagoloff, A., and C. L. Dieckmann.
1990.
PET genes of Saccharomyces cerevisiae.
Microbiol. Rev.
54:211-225[Abstract/Free Full Text].
|
| 55.
|
Velours, J.,
C. Spannagel,
S. Chaignepain,
J. Vaillier,
G. Arselin,
P. V. Graves,
G. Velours, and N. Camougrand.
1998.
Topography of the yeast ATP synthase F0 sector.
Biochimie
80:793-801[Medline].
|
| 56.
|
Wiesenberger, G.,
M. C. Costanzo, and T. D. Fox.
1995.
Analysis of the Saccharomyces cerevisiae mitochondrial COX3 mRNA 5'-untranslated leader: translational activation and mRNA processing.
Mol. Cell. Biol.
15:3291-3300[Abstract].
|
| 57.
|
Wollman, F. A.,
L. Minai, and R. Nechushtai.
1999.
The biogenesis and assembly of photosynthetic proteins in thylakoid membranes.
Biochim. Biophys. Acta
1411:21-85[Medline].
|
| 58.
|
Yaffe, M. P.
1991.
Analysis of mitochondrial function and assembly.
Methods Enzymol.
194:627-643[Medline].
|
| 59.
|
Zuker, M.,
D. H. Mathews, and D. H. Turner.
1999.
Algorithms and thermodynamics for RNA secondary structure prediction: a practical guide, p. 11-43.
In
J. Barciszewski, and B. F. C. Clark (ed.), RNA biochemistry and biotechnology. Kluwer Academic Publishers, Dordrecht, Holland.
|
Molecular and Cellular Biology, April 2001, p. 2359-2372, Vol. 21, No. 7
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.7.2359-2372.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Prestele, M., Vogel, F., Reichert, A. S., Herrmann, J. M., Ott, M.
(2009). Mrpl36 Is Important for Generation of Assembly Competent Proteins during Mitochondrial Translation. Mol. Biol. Cell
20: 2615-2625
[Abstract]
[Full Text]
-
Tavares-Carreon, F., Camacho-Villasana, Y., Zamudio-Ochoa, A., Shingu-Vazquez, M., Torres-Larios, A., Perez-Martinez, X.
(2008). The Pentatricopeptide Repeats Present in Pet309 Are Necessary for Translation but Not for Stability of the Mitochondrial COX1 mRNA in Yeast. J. Biol. Chem.
283: 1472-1479
[Abstract]
[Full Text]
-
Fiumera, H. L., Broadley, S. A., Fox, T. D.
(2007). Translocation of Mitochondrially Synthesized Cox2 Domains from the Matrix to the Intermembrane Space. Mol. Cell. Biol.
27: 4664-4673
[Abstract]
[Full Text]
-
Williams, E. H., Butler, C. A., Bonnefoy, N., Fox, T. D.
(2007). Translation Initiation in Saccharomyces cerevisiae Mitochondria: Functional Interactions Among Mitochondrial Ribosomal Protein Rsm28p, Initiation Factor 2, Methionyl-tRNA-Formyltransferase and Novel Protein Rmd9p. Genetics
175: 1117-1126
[Abstract]
[Full Text]
-
Duvezin-Caubet, S., Rak, M., Lefebvre-Legendre, L., Tetaud, E., Bonnefoy, N., di Rago, J.-P.
(2006). A "Petite Obligate" Mutant of Saccharomyces cerevisiae: FUNCTIONAL mtDNA IS LETHAL IN CELLS LACKING THE {delta} SUBUNIT OF MITOCHONDRIAL F1-ATPASE. J. Biol. Chem.
281: 16305-16313
[Abstract]
[Full Text]
-
Su, X., Dowhan, W.
(2006). Translational Regulation of Nuclear Gene COX4 Expression by Mitochondrial Content of Phosphatidylglycerol and Cardiolipin in Saccharomyces cerevisiae. Mol. Cell. Biol.
26: 743-753
[Abstract]
[Full Text]
-
Williams, E. H., Bsat, N., Bonnefoy, N., Butler, C. A., Fox, T. D.
(2005). Alteration of a Novel Dispensable Mitochondrial Ribosomal Small-Subunit Protein, Rsm28p, Allows Translation of Defective COX2 mRNAs. Eukaryot Cell
4: 337-345
[Abstract]
[Full Text]
-
Lemaire, C., Guibet-Grandmougin, F., Angles, D., Dujardin, G., Bonnefoy, N.
(2004). A Yeast Mitochondrial Membrane Methyltransferase-like Protein Can Compensate for oxa1 Mutations. J. Biol. Chem.
279: 47464-47472
[Abstract]
[Full Text]
-
Williams, E. H., Perez-Martinez, X., Fox, T. D.
(2004). MrpL36p, a Highly Diverged L31 Ribosomal Protein Homolog With Additional Functional Domains in Saccharomyces cerevisiae Mitochondria. Genetics
167: 65-75
[Abstract]
[Full Text]
-
Towpik, J., Chacinska, A., Ciesla, M., Ginalski, K., Boguta, M.
(2004). Mutations in the Yeast MRF1 Gene Encoding Mitochondrial Release Factor Inhibit Translation on Mitochondrial Ribosomes. J. Biol. Chem.
279: 14096-14103
[Abstract]
[Full Text]
-
Herrmann, J. M., Bonnefoy, N.
(2004). Protein Export across the Inner Membrane of Mitochondria: THE NATURE OF TRANSLOCATED DOMAINS DETERMINES THE DEPENDENCE ON THE Oxa1 TRANSLOCASE. J. Biol. Chem.
279: 2507-2512
[Abstract]
[Full Text]
-
Golik, P., Bonnefoy, N., Szczepanek, T., Saint-Georges, Y., Lazowska, J.
(2003). The Rieske FeS protein encoded and synthesized within mitochondria complements a deficiency in the nuclear gene. Proc. Natl. Acad. Sci. USA
100: 8844-8849
[Abstract]
[Full Text]
-
Fiori, A., Mason, T. L., Fox, T. D.
(2003). Evidence that Synthesis of the Saccharomyces cerevisiae Mitochondrially Encoded Ribosomal Protein Var1p May Be Membrane Localized. Eukaryot Cell
2: 651-653
[Abstract]
[Full Text]
-
WILLIAMS, E. H., FOX, T. D.
(2003). Antagonistic signals within the COX2 mRNA coding sequence control its translation in Saccharomyces cerevisiae mitochondria. RNA
9: 419-431
[Abstract]
[Full Text]
-
Islas-Osuna, M. A., Ellis, T. P., Marnell, L. L., Mittelmeier, T. M., Dieckmann, C. L.
(2002). Cbp1 Is Required for Translation of the Mitochondrial Cytochrome b mRNA of Saccharomyces cerevisiae. J. Biol. Chem.
277: 37987-37990
[Abstract]
[Full Text]
-
Broadley, S. A., Demlow, C. M., Fox, T. D.
(2001). Peripheral Mitochondrial Inner Membrane Protein, Mss2p, Required for Export of the Mitochondrially Coded Cox2p C Tail in Saccharomyces cerevisiae. Mol. Cell. Biol.
21: 7663-7672
[Abstract]
[Full Text]